At the time of the approval, John Sharretts, M.D., director of the Division of Diabetes, Lipid Disorders, and Obesity in the FDAs Center for Drug Evaluation and Research, said, Wegovy is now the first weight loss medication to also be approved to help prevent life-threatening cardiovascular events in adults with cardiovascular disease and either obesity or overweight
Help from healthcare professionals and counselors is available for people dependent on AASs.
After drawing up the sterile water and performing the reconstitution, promptly discard the empty vial or ampule and any remaining water
This may improve mood, clarity, and cognitive function
As the guidance in PubMed Central recommends, when semaglutide is withdrawn, providers should have alternative strategies in place for ongoing weight management to avoid potential relapse into previous health conditions
Plaintiff Geoffrey Symonds claims he lost 85% of the vision in one eye after taking Ozempic for less than three months, from November 2021 to January 2022